Target Audience Medical Inc is categorized under Entertainment Services in New York City, NY and active since 2002.
Target Audience Medical Inc was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Entertainment Services business, which does work in the B2C market, and is classified as a Entertainment Services, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Lance Spiro at the company’s single location by writing to 30 West 63rd St Apartment 24g, New York City, New York NY 10023 or by phoning (212) 489-3946. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Target Audience Medical Inc |
| Contact Person: | Lance Spiro |
| Address: | 30 West 63rd St Apartment 24g, New York City, New York 10023 |
| Phone Number: | (212) 489-3946 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Entertainment Services |
| SIC Code: | 7929 |
| NAICS Code: | 9999900 |
| Share This Business: |
Target Audience Medical Inc was started in 2002 to provide professional Entertainment Services under the SIC code 7929 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Lance Spiro for inquiries that concern Target Audience Medical Inc by calling the company number (212) 489-3946, as your correspondence is most welcome. Additionally, the physical location of the single location of Target Audience Medical Inc can be found at the coordinates 40.771079,-73.981555 as well as the street address 30 West 63rd St Apartment 24g in New York City, New York 10023.
For its online presence, you may visit Target Audience Medical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.